October 15th 2026, 6:11 PM
AI Healthcare Firms Get $500M Boost
Key Summary
KKR-backed Catalio Capital is raising $500 million to invest in startups that combine artificial intelligence with healthcare, following successful fundraising efforts in 2025 and 2026. The firm has a history of logging over 20 exits and managing $2 billion in assets. Its advisory board includes notable figures from the worlds of buyouts and big pharma.
Please see our real time news feed on our Home Page
Fundraising Details
Catalio Capital Management wants $500 million to back startups where artificial intelligence meets healthcare.Background
Catalio is a New York investment firm founded in 2020. KKR & Co. has held a partial stake in it since 2023.Recent Fundraising Efforts
The firm has closed two funds above target since mid-2025 and is now back in the market.Notable Recent Move
Catalio led a $311 million Series E round for Enveda Therapeutics in September 2026, doubling the company's valuation to approximately $2 billion.What This Means for Healthcare Investors
Whether this raise lands at, above, or below $500 million will be a useful signal of appetite for the AI-plus-biomedicine thesis.Catalio Capital Management, KKR & Co., Enveda Therapeutics
Regulatory Enforcement
- \1\1\1
A photo of a doctor using a computer to analyze medical images, with a cityscape in the background, symbolizing the intersection of healthcare and technology.
#AI#Healthcare#KKR#CatalioCapital#Fintech